Your browser doesn't support javascript.
loading
Improved pulmonary function and exercise tolerance despite persistent pulmonary fibrosis over 1 year after severe COVID-19 infection.
McGroder, Claire F; Salvatore, Mary M; D'Souza, Belinda M; Hoffman, Eric A; Baldwin, Matthew R; Garcia, Christine Kim.
Afiliación
  • McGroder CF; Medicine/Pulmonary, Allergy, and Critical Care Medicine, Columbia University Irving Medical Center, New York, New York, USA.
  • Salvatore MM; Radiology, Columbia University Medical Center, New York, New York, USA.
  • D'Souza BM; Radiology, Columbia University Medical Center, New York, New York, USA.
  • Hoffman EA; Radiology/Medicine/Biomedical Engineering, University of Iowa Carver College of Medicine, Iowa City, Iowa, USA.
  • Baldwin MR; Medicine/Pulmonary, Allergy, and Critical Care Medicine, Columbia University Irving Medical Center, New York, New York, USA.
  • Garcia CK; Medicine/Pulmonary, Allergy, and Critical Care Medicine, Columbia University Irving Medical Center, New York, New York, USA ckg2116@cumc.columbia.edu.
Thorax ; 79(5): 472-475, 2024 Apr 15.
Article en En | MEDLINE | ID: mdl-38514184
ABSTRACT
We conducted a prospective single-centre cohort study of 104 multi-ethnic severe COVID-19 survivors from the first wave of the pandemic 15 months after hospitalisation. Of those who were assessed at 4 and 15 months, improvement of ground glass opacities correlated with worsened fibrotic reticulations. Despite a high prevalence of fibrotic patterns (64%), pulmonary function, grip strength, 6 min walk distance and frailty normalised. Overall, dyspnoea, cough and exhaustion did not improve and were not correlated with pulmonary function or radiographic fibrosis at 15 months, suggesting non-respiratory aetiologies. Monitoring persistent, and often subclinical, fibrotic interstitial abnormalities will be needed to determine their potential for future progression.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Fibrosis Pulmonar / COVID-19 Límite: Humans Idioma: En Revista: Thorax Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Fibrosis Pulmonar / COVID-19 Límite: Humans Idioma: En Revista: Thorax Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido